NVN Liquidation Inc (NOVNQ)
0.0008
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
NVN Liquidation Cash from Investing (TTM): -5.961M for March 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -5.961M |
| December 31, 2022 | -18.86M |
| September 30, 2022 | -21.82M |
| June 30, 2022 | -19.51M |
| March 31, 2022 | -19.51M |
| December 31, 2021 | -7.527M |
| September 30, 2021 | -3.536M |
| June 30, 2021 | -2.594M |
| March 31, 2021 | -0.723M |
| December 31, 2020 | -0.126M |
| September 30, 2020 | -0.474M |
| June 30, 2020 | -0.731M |
| March 31, 2020 | -0.742M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.422M |
| September 30, 2019 | -0.268M |
| June 30, 2019 | -0.728M |
| March 31, 2019 | -0.935M |
| December 31, 2018 | -1.058M |
| September 30, 2018 | -1.171M |
| June 30, 2018 | -1.362M |
| March 31, 2018 | -1.704M |
| December 31, 2017 | -2.142M |
| September 30, 2017 | -4.532M |
| June 30, 2017 | -4.952M |
| March 31, 2017 | -6.224M |
| December 31, 2016 | -6.218M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-21.82M
Minimum
Sep 2022
-0.126M
Maximum
Dec 2020
-6.471M
Average
-1.668M
Median
Cash from Investing (TTM) Benchmarks
| Cantabio Pharmaceuticals Inc | -- |
| Q BioMed Inc | -- |
| Affymax Inc | -- |
| Scopus BioPharma Inc | 0.00 |
| Statera BioPharma Inc | -0.1034M |